U3N-31861-36278
2 vaccinations
1 coded response
24 check-ins
1 free-text entry
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 201 / VA
- Registered
- 2021-07-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-07-11
Registered in v-safe
-
2021-07-11
Dose 1 — Pfizer-BioNTech
- 2021-07-11
- 2021-07-12
-
2021-07-13
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
- 2021-07-14
- 2021-07-15
- 2021-07-16
- 2021-07-17
- 2021-07-18
- 2021-07-25
-
2021-08-01
Dose 2 — Pfizer-BioNTech
-
2021-08-01
Health check-in — day 0, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tirednessAdult check-in
-
2021-08-02
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness · Be unable to work or attend schoolAdult check-in
-
2021-08-03
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Fatigue or tiredness, Nausea · Be unable to work or attend schoolAdult check-in
- 2021-08-04
- 2021-08-06
- 2021-08-07
- 2021-08-08
- 2021-08-15
- 2021-08-22
- 2021-08-29
- 2021-09-05
- 2021-09-12
- 2021-10-31
- 2022-01-30
-
2022-08-03
Survey response — 12 months, dose 2MedDRA: Cough, Headache, Oropharyngeal pain, Pyrexia, Rhinorrhoea — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitFree text: Cough, runny nose, fever, headache, sore throat.MedDRA releases: 2024-11 · check-in free text available
-
2022-08-03
Report sent to call center — 12 months, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
- 2022-08-04
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-07-11 | Pfizer-BioNTech | No |
| 2 | 2021-08-01 | Pfizer-BioNTech | No |
Call center
1 call center case
1 unsuccessful
Free text
Release 12 — 12 months, dose 2
Symptoms: Cough, runny nose, fever, headache, sore throat.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Cough | · | · | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release